United States Recombinant Protein Market was valued at USD 12.00 Billion in 2022 and is projected to reach USD 26.00 Billion by 2030, growing at a CAGR of 10.10% from 2024 to 2030.
The US recombinant protein market has been experiencing significant growth due to the increasing demand for advanced therapies and the rising use of proteins in various industries. Recombinant proteins, which are proteins produced by recombinant DNA technology, are essential in a wide range of applications, including medicine, biotechnology, and research. These proteins are vital for developing new drugs, vaccines, and diagnostic tools, making them a cornerstone in the health and pharmaceutical sectors.
In the medical field, recombinant proteins play a crucial role in the production of therapeutic proteins such as insulin, growth hormones, and monoclonal antibodies. These products have revolutionized the treatment of diseases such as diabetes, cancer, and genetic disorders. The growing prevalence of chronic diseases in the US has directly impacted the demand for recombinant proteins, driving the market's expansion. Furthermore, the biotech industry is increasingly relying on these proteins for drug development and personalized medicine, further accelerating market growth.
The requirement for recombinant proteins is not only limited to the medical and pharmaceutical sectors. They are also extensively used in the food and agriculture industries, where they are involved in the development of genetically modified organisms (GMOs) and the production of animal feed. Additionally, the growing demand for recombinant proteins in industrial processes such as enzyme production and fermentation is contributing to the overall market expansion.
Technological advancements in protein expression systems and improvements in production techniques have made recombinant proteins more cost-effective and scalable. This has led to an increased adoption of these proteins across various sectors. The availability of high-quality recombinant proteins at competitive prices is expected to continue to drive the market forward, allowing industries to explore new applications and further expand their use.
The US recombinant protein market's future looks promising as both established and emerging industries recognize the value and versatility of recombinant proteins. With innovations in biotechnology, the potential applications of recombinant proteins will only continue to grow, making them indispensable for both therapeutic and industrial purposes.
Get an In-Depth Research Analysis of the US Recombinant Protein Market Size And Forecast [2025-2032]
R&D Systems
ProSpec
Thermo Fisher Scientific
GenScript
FiberCell Systems€Ž
Applied Biological Materials Inc Peprotech
Chimerigen
Origene
NOVUS
Abnova
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Recombinant Protein Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Recombinant Protein Market
Recombinant Therapeutics
Recombinant Vaccines
Recombinant Hormones
Recombinant Enzymes
Recombinant Antibodies
Microbial Source
Animal Cell Culture
Plant Cell Culture
Insect Cell Culture
Research and Development
Diagnostics
Therapeutics
Industrial Biotechnology
Pharmaceutical Companies
Biosimilar Manufacturers
Academic and Research Institutions
Contract Research Organizations (CROs)
Parenteral
Oral
Topical
Other Novel Delivery Systems
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Recombinant Protein Market Research Analysis
1. Introduction of the US Recombinant Protein Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Recombinant Protein Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Recombinant Protein Market, By Type
6. US Recombinant Protein Market, By Application
7. US Recombinant Protein Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Recombinant Protein Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/